Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang NHU is a publicly traded Chinese fine chemicals and health-related ingredients company focused on the R&D, manufacturing, and sale of nutritional products, flavor and fragrance ingredients, APIs, feed additives, and advanced materials. The company was founded in 1999 and is listed on the Shenzhen Stock Exchange under ticker 002001. In health-related markets, NHU is best known for large-scale commercial production of vitamins, carotenoids, biotin, coenzyme Q10, methionine, food/feed additives, and selected pharmaceutical intermediates and APIs. Its business model is industrial manufacturing rather than novel drug discovery, with operations spanning headquarters and research in Xinchang and major production bases in Zhejiang, Shandong, and Heilongjiang. For a biotech analyst, this is best understood as a diversified commercial life-science ingredients and specialty chemicals manufacturer with some pharma/API exposure, not a clinical-stage biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang NHU.